These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 7878075

  • 21. Contribution of intercellular adhesion molecule 1 (ICAM-1) to the pathogenesis of splanchnic artery occlusion shock in the rat.
    Squadrito F, Altavilla D, Canale P, Ioculano MP, Campo GM, Ammendolia L, Squadrito G, Saitta A, Calapai G, Caputi AP.
    Br J Pharmacol; 1994 Nov; 113(3):912-6. PubMed ID: 7858885
    [Abstract] [Full Text] [Related]

  • 22. G619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, reduces myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion in rats.
    Squadrito F, Ioculano M, Altavilla D, Zingarelli B, Canale P, Campo GM, Saitta A, Oriti S, Spignoli G, Caputi AP.
    Pharmacology; 1993 Sep; 47(3):167-75. PubMed ID: 8415867
    [Abstract] [Full Text] [Related]

  • 23. Intestinal and arterial plasma thromboxane and prostacyclin levels in shock: effects of indomethacin.
    Mózes T, Wieszt E.
    J Surg Res; 1989 Dec; 47(6):482-6. PubMed ID: 2511379
    [Abstract] [Full Text] [Related]

  • 24. Protective effects of cyclosporin-A in splanchnic artery occlusion shock.
    Squadrito F, Altavilla D, Squadrito G, Ferlito M, Deodato B, Arlotta M, Minutoli L, Campo GM, Bova A, Quartarone C, Urna G, Sardella A, Saitta A, Caputi AP.
    Br J Pharmacol; 2000 May; 130(2):339-44. PubMed ID: 10807671
    [Abstract] [Full Text] [Related]

  • 25. Use of a novel peptide leukotriene receptor antagonist, Ly-163443, in splanchnic artery occlusion shock.
    Bitterman H, Lefer AM.
    Prostaglandins Leukot Essent Fatty Acids; 1988 May; 32(2):63-70. PubMed ID: 3406041
    [Abstract] [Full Text] [Related]

  • 26. Beneficial actions of thromboxane receptor antagonism in hemorrhagic shock.
    Bitterman H, Yanagisawa A, Lefer AM.
    Circ Shock; 1986 May; 20(1):1-11. PubMed ID: 2945667
    [Abstract] [Full Text] [Related]

  • 27. Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock.
    Squadrito F, Guarini S, Altavilla D, Squadrito G, Campo GM, Arlotta M, Quartarone C, Saitta A, Cucinotta D, Bazzani C, Cainazzo MM, Mioni C, Bertolini A, Caputi AP.
    Br J Pharmacol; 1999 Oct; 128(3):816-22. PubMed ID: 10516667
    [Abstract] [Full Text] [Related]

  • 28. G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, inhibits tumor necrosis factor-alpha biosynthesis.
    Altavilla D, Squadrito F, Canale P, Ioculano M, Squadrito G, Campo GM, Serranò M, Sardella A, Urna G, Spignoli G.
    Eur J Pharmacol; 1995 Nov 03; 286(1):31-9. PubMed ID: 8566149
    [Abstract] [Full Text] [Related]

  • 29. Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock.
    Squadrito F, Altavilla D, Squadrito G, Campo GM, Arlotta M, Quartarone C, Saitta A, Caputi AP.
    Br J Pharmacol; 1999 May 03; 127(2):482-8. PubMed ID: 10385249
    [Abstract] [Full Text] [Related]

  • 30. WY 14643, a potent exogenous PPAR-alpha ligand, reduces intestinal injury associated with splanchnic artery occlusion shock.
    Cuzzocrea S, Di Paola R, Mazzon E, Genovese T, Muià C, Caputi AP.
    Shock; 2004 Oct 03; 22(4):340-6. PubMed ID: 15377889
    [Abstract] [Full Text] [Related]

  • 31. BAY u3405 an antagonist of thromboxane A2- and prostaglandin D2-induced bronchoconstriction in the guinea-pig.
    Francis HP, Greenham SJ, Patel UP, Thompson AM, Gardiner PJ.
    Br J Pharmacol; 1991 Nov 03; 104(3):596-602. PubMed ID: 1797323
    [Abstract] [Full Text] [Related]

  • 32. Leukocyte integrin very late antigen-4/vascular cell adhesion molecule-1 adhesion pathway in splanchnic artery occlusion shock.
    Squadrito F, Altavilla D, Ammendolia L, Squadrito G, Campo GM, Canale P, Ioculano M, Musolino C, Alonci A, Saitta A, Rossi F, Caputi AP.
    Eur J Pharmacol; 1996 Dec 27; 318(1):153-60. PubMed ID: 9007527
    [Abstract] [Full Text] [Related]

  • 33. Monocytes and lymphocytes as active participants in the pathogenesis of experimental shock.
    Altavilla D, Squadrito F, Ammendolia L, Squadrito G, Campo GM, Canale P, Ioculano M, Musolino C, Alonci A, Sardella A, Urna G, Saitta A, Caputi AP.
    Inflamm Res; 1996 Aug 27; 45(8):398-404. PubMed ID: 8872513
    [Abstract] [Full Text] [Related]

  • 34. Beneficial effects of GPI 6150, an inhibitor of poly(ADP-ribose) polymerase in a rat model of splanchnic artery occlusion and reperfusion.
    Mazzon E, Dugo L, De SA, Li JH, Caputi AP, Zhang J, Cuzzocrea S.
    Shock; 2002 Mar 27; 17(3):222-7. PubMed ID: 11900342
    [Abstract] [Full Text] [Related]

  • 35. Participation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shock.
    Squadrito F, Altavilla D, Canale P, Ioculano M, Campo GM, Ammendolia L, Ferlito M, Zingarelli B, Squadrito G, Saitta A.
    Br J Pharmacol; 1994 Dec 27; 113(4):1153-8. PubMed ID: 7889268
    [Abstract] [Full Text] [Related]

  • 36. Protective effect of cloricromene, a coumarine derivative, in hypovolemic hemorrhagic shock in the rat.
    Sturniolo R, Squadrito F, Campo GM, Vinci R, Calatroni A, Prosdocimi M, Caputi AP.
    J Cardiovasc Pharmacol; 1991 Feb 27; 17(2):261-6. PubMed ID: 1709231
    [Abstract] [Full Text] [Related]

  • 37. Splanchnic artery occlusion shock in the rat: effects of the calcium entry blockers nimodipine and verapamil.
    Sturniolo R, Altavilla D, Berlinghieri MC, Squadrito F, Caputi AP.
    Circ Shock; 1988 Feb 27; 24(1):43-53. PubMed ID: 3345594
    [Abstract] [Full Text] [Related]

  • 38. Effect of a novel thromboxane A2 receptor antagonist, S-1452, on postischemic brain injury in rats.
    Matsuo Y, Izumiyama M, Onodera H, Kurosawa A, Kogure K.
    Stroke; 1993 Dec 27; 24(12):2059-64; discussion 2064-5. PubMed ID: 8248988
    [Abstract] [Full Text] [Related]

  • 39. Beneficial effects of combined thromboxane and leukotriene receptor antagonism in hemorrhagic shock.
    Patel JP, Beck LD, Briglia FA, Hock CE.
    Crit Care Med; 1995 Feb 27; 23(2):231-7. PubMed ID: 7867347
    [Abstract] [Full Text] [Related]

  • 40. Beneficial mechanisms of action of a prostacyclin enhancing agent in splanchnic artery occlusion shock.
    Aoki N, Siegfried M, Tsao P, Lento P, Lefer AM.
    Res Commun Chem Pathol Pharmacol; 1988 Jun 27; 60(3):275-89. PubMed ID: 3175328
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.